WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer
- PMID: 34911552
- PMCID: PMC8672621
- DOI: 10.1186/s13046-021-02187-z
WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer
Abstract
Background: Breast cancer has been associated with activation of the WNT signaling pathway, although no driver mutations in WNT genes have been found yet. Instead, a high expression of the alternative WNT receptor ROR2 was observed, in particular in breast cancer brain metastases. However, its respective ligand and downstream signaling in this context remained unknown.
Methods: We modulated the expression of ROR2 in human breast cancer cells and characterized their gene and protein expression by RNA-Seq, qRT-PCR, immunoblots and reverse phase protein array (RPPA) combined with network analyses to understand the molecular basis of ROR2 signaling in breast cancer. Using co-immunoprecipitations, we verified the interaction of ROR2 with the identified ligand, WNT11. The functional consequences of WNT11/ROR2 signaling for tumor cell aggressiveness were assessed by microscopy, impedance sensing as well as viability and invasion assays. To evaluate the translational significance of our findings, we performed gene set enrichment, expression and survival analyses on human breast cancer brain metastases.
Results: We found ROR2 to be highly expressed in aggressive breast tumors and associated with worse metastasis-free survival. ROR2 overexpression induced a BRCAness-like phenotype in a cell-context specific manner and rendered cells resistant to PARP inhibition. High levels of ROR2 were furthermore associated with defects in cell morphology and cell-cell-contacts leading to increased tumor invasiveness. On a molecular level, ROR2 overexpression upregulated several non-canonical WNT ligands, in particular WNT11. Co-immunoprecipitation confirmed that WNT11 indeed interacts with the cysteine-rich domain of ROR2 and triggers its invasion-promoting signaling via RHO/ROCK. Knockdown of WNT11 reversed the pro-invasive phenotype and the cellular changes in ROR2-overexpressing cells.
Conclusions: Taken together, our study revealed a novel auto-stimulatory loop in which ROR2 triggers the expression of its own ligand, WNT11, resulting in enhanced tumor invasion associated with breast cancer metastasis.
Keywords: BRCAness; Breast cancer; Metastasis; Network analysis; ROR2; WNT11.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Ror2 receptor mediates Wnt11 ligand signaling and affects convergence and extension movements in zebrafish.J Biol Chem. 2014 Jul 25;289(30):20664-76. doi: 10.1074/jbc.M114.586099. J Biol Chem. 2014. PMID: 24928507 Free PMC article.
-
Ror2 Signaling and Its Relevance in Breast Cancer Progression.Front Oncol. 2017 Jun 26;7:135. doi: 10.3389/fonc.2017.00135. eCollection 2017. Front Oncol. 2017. PMID: 28695110 Free PMC article.
-
MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.Oncol Rep. 2015 Oct;34(4):2195-201. doi: 10.3892/or.2015.4186. Epub 2015 Aug 10. Oncol Rep. 2015. Retraction in: Oncol Rep. 2021 Aug;46(2):156. doi: 10.3892/or.2021.8107. PMID: 26259653 Retracted.
-
Insight into the role of Wnt5a-induced signaling in normal and cancer cells.Int Rev Cell Mol Biol. 2015;314:117-48. doi: 10.1016/bs.ircmb.2014.10.003. Epub 2014 Nov 18. Int Rev Cell Mol Biol. 2015. PMID: 25619716 Review.
-
Wnt11 in 2011 - the regulation and function of a non-canonical Wnt.Acta Physiol (Oxf). 2012 Jan;204(1):52-64. doi: 10.1111/j.1748-1716.2011.02297.x. Epub 2011 May 7. Acta Physiol (Oxf). 2012. PMID: 21447091 Review.
Cited by
-
Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.J Exp Clin Cancer Res. 2022 May 2;41(1):161. doi: 10.1186/s13046-022-02370-w. J Exp Clin Cancer Res. 2022. PMID: 35501821 Free PMC article. Review.
-
WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis.Nat Commun. 2025 Feb 7;16(1):1429. doi: 10.1038/s41467-025-56714-z. Nat Commun. 2025. PMID: 39920102 Free PMC article.
-
Ror2 signaling regulated by differential Wnt proteins determines pathological fate of muscle mesenchymal progenitors.Cell Death Dis. 2024 Oct 29;15(10):784. doi: 10.1038/s41419-024-07173-9. Cell Death Dis. 2024. PMID: 39468010 Free PMC article.
-
ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling.Oncol Res. 2024 Jun 20;32(7):1209-1219. doi: 10.32604/or.2024.045433. eCollection 2024. Oncol Res. 2024. PMID: 38948021 Free PMC article.
-
Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma.iScience. 2024 Dec 13;28(1):111589. doi: 10.1016/j.isci.2024.111589. eCollection 2025 Jan 17. iScience. 2024. PMID: 39829682 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767–779. - PubMed
-
- De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin. 2011;43:745–756. - PubMed
-
- Habas R, Kato Y, He X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell. 2001;107:843–854. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous